ELOX
Eloxx Pharmaceuticals, Inc.
13.90$
+1.1%
vs. previous close
Closing price · As of: Oct 12, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +17.3% | -42.2% | -6.0% | +220.4% | -33.1% | +95.3% | -38.2% | -19.1% | +2.1% | +369.7% | -41.4% | -52.8% | +168.6% | +104.6% | +16.2% | -55.1% | +70.5% | -53.2% | -91.9% | +73.8% | +77.1% | |
| – | +3.8% | -70.2% | -41.7% | +733.7% | -59.2% | +260.0% | -45.8% | -29.8% | -0.8% | +105.2% | -48.4% | -73.7% | +2,393.9% | +105.4% | +14.6% | -55.1% | +67.9% | -53.7% | -92.3% | +92.2% | +77.1% | |
| – | +56.7% | +9.1% | +28.1% | +1,291.2% | -93.3% | +2,009.0% | -55.0% | – | – | +281.4% | -45.4% | -75.7% | +2,878.6% | +101.4% | -53.7% | +9.7% | +72.2% | -54.3% | -94.2% | -90.2% | +4,216.2% | |
| – | +2.4% | -72.4% | -43.7% | +838.7% | -76.8% | +461.1% | -55.0% | -44.6% | -19.9% | +281.4% | -45.4% | -75.7% | +2,878.6% | +101.4% | +15.8% | -56.1% | +72.2% | -54.3% | -94.2% | -90.2% | +4,216.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | -58.4% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -3.7% | – | – | -18.2% | -17.3% | – | – | – | – | – | – | – | – | – | |
| – | +9.0% | +11.5% | +8.4% | +27.7% | +80.2% | +307.7% | -31.2% | -16.6% | -5.6% | +82.0% | +25.3% | -36.3% | -26.6% | +128.1% | +191.2% | -28.5% | +40.1% | +39.7% | -23.5% | +12.3% | -37.1% | |
| – | +10.5% | +4.3% | +12.0% | +36.0% | +94.7% | +149.8% | -1.8% | -3.2% | +1.5% | -43.2% | -57.3% | -52.6% | +827.7% | +128.1% | +51.2% | -16.7% | +1.2% | +132.0% | -1.7% | +20.3% | -37.1% | |
| – | – | – | – | – | – | – | +0.2% | +0.0% | -0.5% | – | – | – | – | – | – | +16.4% | -88.3% | +614.2% | -49.9% | +177.2% | -84.7% | |
| – | +215.3% | -64.3% | +40.6% | +238.8% | +163.8% | -42.9% | +0.4% | +6.3% | +7.2% | – | – | – | – | -51.2% | +150.5% | -74.3% | +186.7% | +119.0% | +88.7% | -6.2% | -49.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -81.2% | – | – | |
| – | +18.2% | -47.2% | -8.9% | +265.7% | -42.4% | +40.8% | -43.4% | -23.6% | +9.6% | +626.1% | -55.5% | -62.7% | +368.4% | +100.9% | -15.6% | -71.8% | +118.8% | -147.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +10.9% | +10.1% | +9.3% | +4.4% | +6.9% | +54.1% | +138.2% | +23.6% | +59.4% | +300.8% | +163.2% | +41.0% | +389.8% | +551.9% | +17.3% | +5.4% | +74.4% | +23.9% | +18.7% | +46.2% | +228.5% |
Data as of: October 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.